COVID‐19 is a complex disease, and many difficulties are faced today especially in the
proper choice of pharmacological treatments. The role of antiviral agents for COVID‐19 is …

Globally, there have been close to 130 million reported cases of coronavirus disease 2019
(COVID-19) as of 2nd April 2021, with 2.8 million deaths documented [1]. In order to reduce …

Immunothrombosis is a potentially beneficial physiological process that aids innate immunity
and host defense against pathogen invasion. However, this process can also be damaging …

Sepsis is a common condition that is associated with significant morbidity, mortality and
health-care cost. Pulmonary and non-pulmonary sepsis are common causes of the acute …

Despite their humble origins as anuclear fragments of megakaryocytes, platelets have
emerged as versatile mediators of thrombosis and immunity. The diverse spectrum of …

Background: The acute respiratory distress syndrome (ARDS) is a life-threating disorder that
contributes significantly to critical illness. No specific pharmacological interventions directed …

Purpose Abnormal platelet activation plays an important role in the development of sepsis.
The effect of antiplatelet drugs on the outcome of patients with sepsis remains unclear. This …

Abstract Development of organ failure is one of the major determinants of mortality in
patients with acute pancreatitis (AP). Acute respiratory distress syndrome (ARDS) is an …

Early identification of patients with COVID-19 who will develop severe or critical disease
symptoms is important for delivering proper and early treatment. We analyzed demographic …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the complicated
disease COVID-19. Clinicians are continuously facing huge problems in the treatment of …